Mortality and Shock in CLABSI with Retained Catheters
Patients with CLABSI who retain their central line face a mortality rate approaching 40-46%, compared to only 4% mortality when the catheter is promptly removed, representing a 13.5-fold increased risk of death within 30 days.
Mortality Data
The most recent and highest-quality evidence demonstrates stark mortality differences based on catheter management:
In low- and middle-income countries (LMICs), patients with CLABSI experienced a 39.81% mortality rate compared to 14.06% in patients without healthcare-associated infections, based on pooled data from 630 ICUs across 45 countries covering 204,770 patients and 4,270 CLABSIs 1.
When catheters are retained, mortality reaches 45.3% in patients with multidrug-resistant organism (MDRO) CLABSIs, compared to only 4.2% mortality when catheters are removed 2.
Failure to remove a central venous catheter is associated with a hazard ratio of 13.5 (95% CI 6.8-26.7) for 30-day all-cause mortality in patients with MDRO CLABSIs 2.
Overall CLABSI-associated mortality shows an odds ratio of 2.75 (95% CI 1.86-4.07) for in-hospital death across 18 studies involving 1,976 CLABSI cases, predominantly in ICU settings 3.
Among patients presenting with CLABSI on hospital admission, 11% died during hospitalization, with mortality risk significantly increased by lack of catheter removal (HR 0.57 for removal, meaning removal reduces mortality by 43%) 4.
Septic Shock Incidence
While the provided evidence does not explicitly quantify septic shock rates separately from mortality, the data reveals:
CLABSI is identified as an independent mortality risk factor through multiple logistic regression analysis in a multinational study of 786 ICUs across 37 countries 1.
Severity of bacteremia (measured by Pitt bacteremia score) is independently associated with mortality (OR 1.41,95% CI 1.18-1.68), suggesting that hemodynamic instability and shock contribute substantially to poor outcomes 5.
Critical Time-Dependent Factors
Delay in catheter removal directly correlates with mortality:
Each additional day of catheter retention after CLABSI onset increases mortality risk (OR 1.10,95% CI 1.02-1.20) 5.
Longer interval between CLABSI onset and catheter removal is an independent predictor of death in multivariate analysis 5.
Pathogen-Specific Considerations
The mortality risk varies by causative organism when catheters are retained:
Gram-negative bacteria cause 39.2% of CLABSIs in critically ill patients, with higher associated mortality than gram-positive organisms 5.
Studies where >30% of CLABSIs were caused by coagulase-negative Staphylococcus showed lower mortality (OR 1.64,95% CI 1.02-2.65) compared to other pathogens (OR 4.71,95% CI 1.54-14.39) 3.
Enterobacterales were the most common etiologic agents (29.2%) in patients presenting with CLABSI on admission 4.
Clinical Implications
The evidence unequivocally demonstrates that catheter retention in CLABSI is associated with catastrophic mortality rates:
Mortality increases from approximately 4% with prompt removal to 40-46% with catheter retention 2.
This represents more than a 10-fold increase in death risk, making catheter removal one of the most impactful interventions in CLABSI management 2.
The relationship is dose-dependent, with each day of delay further increasing mortality risk 5.
Common Pitfalls to Avoid
Do not attempt catheter salvage in the following scenarios:
Any MDRO CLABSI (including methicillin-resistant Staphylococcus aureus, resistant Enterococcus, resistant Enterobacteriaceae, Acinetobacter, or Pseudomonas aeruginosa) 2.
Patients with hemodynamic instability or high Pitt bacteremia scores 5.
Gram-negative CLABSIs, which carry particularly high mortality when catheters are retained 5.
Any delay beyond 72 hours of appropriate antimicrobial therapy without clinical improvement 6.